コンテンツへスキップ
Merck

HIFN-130K-PMX9

MILLIPLEX® Human Interferon Panel

Premixed Human Interferon 9-Plex Panel

別名:

Human Cytokine Panel

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

NACRES:
NA.77
UNSPSC Code:
12161503
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

MILLIPLEX® Human Interferon Panel,

Quality Level

description

Premixed Human Interferon 9-Plex Panel

usage

-1 kit -96 wells

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

parameter

-25 μL sample volume (per well)

technique(s)

multiplexing: suitable

input

plasma
serum
cell culture supernatant(s)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Interferons (IFNs) are widely expressed cytokines that have potent antiviral and antiproliferative effects. These cytokines are the first line of defense against viral infections and have important roles in immunosurveillance for malignant cells. IFNs are classified as type I, II and III IFNs, based upon the target receptors to which they bind. In humans, type I IFNs belong to a multigene family consisting of multiple IFNα subtypes but only one IFNβ, IFNε, IFNκ, and IFNψ. There is only one type II IFN: IFNγ. The type III IFNs include IFNλ1, λ2 and λ3, which are also known as interleukin-29 (IL-29), IL 28A and IL-28B, respectively. Functionally, the type I and type III IFNs are induced during a viral infection and involved in host defense against viruses. IFNγ (type II) is primarily involved in the allergic response, in host defense against intracellular pathogens, and in control of tumor growth. Studies of IFNs have broadened the mechanistic understanding of cell signaling, gene transcription, and innate and acquired immunity.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze 9 analytes in human serum or plasma samples and tissue/cell lysate and culture supernatants.

Analytes included: IFNα-2, IFNβ, IFNε, IFNɣ, IFNɣ Receptor 1, IFNλ1, IFNλ2, IFNλ3, IFNΩ

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Ready-to-Use Convenience: Streamline your workflow with pre-optimized 9-plex premixed reagents, eliminating time-consuming optimization steps for immediate interferon quantification in viral infection and tumor immunosurveillance studies.
  • Simplified Laboratory Operations: Reduce hands-on time and potential errors with convenient premixed format, perfect for high-throughput screening of antiviral responses and immunomodulatory research applications.
  • Innate & Adaptive Immunity Investigation: Advance mechanistic understanding of cell signaling, gene transcription, and immune responses by measuring key interferon mediators across innate and acquired immunity pathways.
  • Luminex® xMAP® Technology Advantage: Leverage proven magnetic bead-based multiplex immunoassay technology for sensitive, specific, and simultaneous quantification of multiple interferon analytes using established Luminex® instrumentation platforms.

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under


signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

保管分類

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

flash_point_f

Not applicable

flash_point_c

Not applicable

wgk

WGK 3


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan



試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする



グローバルトレードアイテム番号

カタログ番号GTIN
HIFN-130K-PMX904065272553186